Cyclopharm

Cyclopharm is an established Australian radiopharmaceutical company servicing the global medical community since 1986.

Cyclopharm is a company in the diagnostic imaging field specialising in lung health. We achieve this positioning through our proprietary medical device and pharmaceutical products under the name of TECHNEGASTM.

TECHNEGASTM has become the industry gold-standard in diagnostic functional lung imaging technology.

We distribute our products in 57 countries throughout the world with over 1500 nuclear medicine departments utilising TECHNEGASTM.

To date, over 4.2 million patient procedures are recorded.

Latest Media Releases

USFDA Approval to File Received for Technegas

27/05/2020 09:28:00

TECHNEGASTM – USFDA NEW DRUG APPLICATION APPROVAL – NEXT MILESTONE IN APPROVAL PROCESS SUCCESSFULLY ACHIEVED :   APPROVAL TO FILE NOTIFICATION RECEIVED TECHNEGAS AP…

Cyclopharm Technegas Approved in Russia

26/05/2020 13:07:00

Cyclopharm Limited (ASX: CYC) is pleased to announce that it has gained regulatory approval to sell its Technegas products in Russia; furthermore, the Company has secured its first order for a Tech…

Latest News